GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » S Biomedics Co Ltd (XKRX:304360) » Definitions » ROE % Adjusted to Book Value

S Biomedics Co (XKRX:304360) ROE % Adjusted to Book Value : -4.96% (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is S Biomedics Co ROE % Adjusted to Book Value?

S Biomedics Co's ROE % for the quarter that ended in Mar. 2024 was -122.14%. S Biomedics Co's PB Ratio for the quarter that ended in Mar. 2024 was 24.61. S Biomedics Co's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was -4.96%.


S Biomedics Co ROE % Adjusted to Book Value Historical Data

The historical data trend for S Biomedics Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

S Biomedics Co ROE % Adjusted to Book Value Chart

S Biomedics Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
ROE % Adjusted to Book Value
Get a 7-Day Free Trial - - - - -

S Biomedics Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -26.31 -5.80 -5.24 -4.96

Competitive Comparison of S Biomedics Co's ROE % Adjusted to Book Value

For the Biotechnology subindustry, S Biomedics Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


S Biomedics Co's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, S Biomedics Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where S Biomedics Co's ROE % Adjusted to Book Value falls into.



S Biomedics Co ROE % Adjusted to Book Value Calculation

S Biomedics Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

S Biomedics Co's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-122.14% / 24.61
=-4.96%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


S Biomedics Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of S Biomedics Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


S Biomedics Co (XKRX:304360) Business Description

Traded in Other Exchanges
N/A
Address
Seongsui-ro 26-gil, 4th Floor, Wooil Venture Town Building 28, Seongdong-gu, FedEx building, Seoul, KOR, 04797
S Biomedics Co Ltd researches and develops cell therapies for regenerative biomedicine. It owns two platform technologies: Functionally Enhanced Cell Spheroid and Targeted Embryonic Stem Cell Differentiation for developing cell therapy products that overcome the limitations of existing cell therapy products.

S Biomedics Co (XKRX:304360) Headlines

No Headlines